Today

Agents

Chat

Arena

Discover

More

App

Ingredion Q2 EPS USD 1.78 - INGR News | Rallies

Ingredion Q2 EPS USD 1.78

INGR•2026-08-04

Q2 results and full-year capex outlook

Aug. 4 (Reuters) - Ingredion Q2 sales USD 1,850 million vs. IBES estimate USD 1,834 million.

Outlook FY capex USD 450-490 million

Related News

Certara Q2 Adjusted EPS USD 0.08 Vs. IBES Estimate USD 0.09

CERT•2026-08-04

Beam Therapeutics Q2 FY26 net loss widens to $122.7 million; revenue drops to $490,000

BEAM•2026-08-04

Strata Critical Q2 adjusted EBITDA rises to $7.9 million; revenue increases 7% year-on-year to $72.5 million

SRTA•2026-08-04

Duke Energy posts Q2 2026 earnings release on website

DUK•2026-08-04

Strata Critical Medical Q2 Revenue USD 72.506 Million Vs. IBES Estimate USD 67.1 Million

SRTA•2026-08-04